California Public Employees Retirement System
CCCC icon

California Public Employees Retirement System’s C4 Therapeutics CCCC Stock Holding History

California Public Employees Retirement System’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-19,490
Closed -$721K – 1782
2021
Q1 		$721K Sell
19,490
-1,839
-9% -$73.2K ﹤0.01% 2727
2020
Q4 		$707K Buy
+21,329
New +$619K ﹤0.01% 2706

Other funds holding CCCC

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ArrowMark Colorado Holdings
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
RA Capital Management
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

California Public Employees Retirement System's CCCC Position: Q2 2021 in Review

California Public Employees Retirement System sold out of C4 Therapeutics (CCCC) in Q2 2021, closing a stake of 19,490 shares — an estimated $721K sold.

California Public Employees Retirement System first reported a position in CCCC in Q4 2020 and held it in 2 quarters. The position peaked at $721K in Q1 2021. 107 funds tracked by Wall St. Rank hold CCCC as of Q2 2021.

  • California Public Employees Retirement System reported no remaining C4 Therapeutics position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 19,490 C4 Therapeutics shares in Q2 2021, an estimated $721K.
  • California Public Employees Retirement System first reported a position in C4 Therapeutics in Q4 2020 and held it in 2 quarters.
  • California Public Employees Retirement System's C4 Therapeutics position peaked at $721K in Q1 2021.
  • 107 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.